Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 4
1983 5
1984 3
1985 4
1986 2
1987 3
1988 6
1989 4
1990 3
1991 1
1992 3
1993 6
1994 4
1995 5
1996 5
1997 5
1998 2
1999 1
2000 8
2003 1
2004 2
2005 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Advances in leishmaniasis.
Murray HW, Berman JD, Davies CR, Saravia NG. Murray HW, et al. Lancet. 2005 Oct 29-Nov 4;366(9496):1561-77. doi: 10.1016/S0140-6736(05)67629-5. Lancet. 2005. PMID: 16257344 Review.
Tropical medicine.
Murray HW, P├ępin J, Nutman TB, Hoffman SL, Mahmoud AA. Murray HW, et al. BMJ. 2000 Feb 19;320(7233):490-4. doi: 10.1136/bmj.320.7233.490. BMJ. 2000. PMID: 10678866 Free PMC article. Review. No abstract available.
Kala-azar as an AIDS-related opportunistic infection.
Murray HW. Murray HW. AIDS Patient Care STDS. 1999 Aug;13(8):459-65. doi: 10.1089/108729199318183. AIDS Patient Care STDS. 1999. PMID: 10800524 Review.
Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
Murray HW. Murray HW. Int J Infect Dis. 2000;4(3):158-77. doi: 10.1016/s1201-9712(00)90078-x. Int J Infect Dis. 2000. PMID: 11179920 Free article. Review.
Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans.
Murray HW. Murray HW. Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):411-21. doi: 10.1016/0732-8893(90)90012-k. Diagn Microbiol Infect Dis. 1990. PMID: 2126500 Review. No abstract available.
Interferon-gamma, the activated macrophage, and host defense against microbial challenge.
Murray HW. Murray HW. Ann Intern Med. 1988 Apr;108(4):595-608. doi: 10.7326/0003-4819-108-4-595. Ann Intern Med. 1988. PMID: 3126690 Review.
Interferon-gamma and host antimicrobial defense: current and future clinical applications.
Murray HW. Murray HW. Am J Med. 1994 Nov;97(5):459-67. doi: 10.1016/0002-9343(94)90326-3. Am J Med. 1994. PMID: 7977435 Review.
Treatment of visceral leishmaniasis in 2004.
Murray HW. Murray HW. Am J Trop Med Hyg. 2004 Dec;71(6):787-94. Am J Trop Med Hyg. 2004. PMID: 15642973 Review.
Current and future clinical applications of interferon-gamma in host antimicrobial defense.
Murray HW. Murray HW. Intensive Care Med. 1996 Oct;22 Suppl 4:S456-61. doi: 10.1007/BF01743724. Intensive Care Med. 1996. PMID: 8923089 Review.
Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
Murray HW. Murray HW. Acta Trop. 2005 Mar;93(3):295-301. doi: 10.1016/j.actatropica.2004.11.008. Acta Trop. 2005. PMID: 15716043
80 results
Jump to page
Feedback